Another level of complexity is involved in this research, as the implications of our results extend beyond KRAS and NSCLC, suggesting the platelet-mediated oncogene transfer could be a broader phenomenon, potentially relevant to other oncogenes and cancer types. The gene discussed is KRAS; the disease is cancer.